Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atom Hi-Tech (Beijing) Pharmaceutical Technology Co., Ltd. is a leading Chinese radiopharmaceutical company specializing in the research, development, production, and distribution of nuclear medicines and radioactive tracers. As a core subsidiary of China Isotope & Radiation Corporation (CIRC), the company provides an extensive portfolio of products including Iodine-131 for thyroid conditions, Technetium-99m generators for diagnostic imaging, and various PET/SPECT radiopharmaceuticals. Atom Hi-Tech operates multiple production bases across China, ensuring a robust supply chain for short-lived isotopes used in oncology and endocrinology. The company is actively expanding its clinical pipeline with next-generation radioligand therapies targeting prostate cancer and neuroendocrine tumors. Its integrated capabilities span from isotope production to final drug formulation and distribution to medical facilities nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atom Hi-Tech.